Sapio GMP LIMS
Public-source research, not a ranking and not a recommendation to buy, reject, or shortlist. Dataset as of 2026-10-04.
- Vendor
- Sapio Sciences
- Category
- LIMS
- Deployment
- General Sapio LIMS page lists cloud or on-premise. Not stated as a GMP-only architecture.
- Pricing stance
- Quote-only
- Regulatory posture
- GMP-oriented LIMS for QC, environmental monitoring, stability, and a 2024 EBR add-on. Platform, ELN, Jarvis, and ELaiN are not this row.
- Independent review
- Passed 2026-10-03
- Sourced claims
- 43
Product: Sapio GMP LIMS (also "Sapio QC LIMS"), with QC, environmental monitoring, and stability modules, and electronic batch records (EBR) since 24 October 2024. No public version number or SKU. Vendor: Sapio Sciences (SAPIO SCIENCES, LLC, UEI Z5DXSDZGWK88). North America HQ 400 East Pratt Street #800, Baltimore, MD 21202; European HQ 210 Euston Road, London NW1 2DA; consulting office 205 N George St, York, PA 17401. Category: GMP laboratory information management for QC, environmental monitoring, stability, and electronic batch records. Not an ERP, MES, QMS, ELN, or scientific data cloud. Verification date: 2026-10-03. Scope: Public web sources only.
1. Overview
Sapio GMP LIMS is the GMP packaging of Sapio Sciences' cloud lab informatics platform, launched in June 2024 with QC, environmental monitoring, and stability modules and extended to electronic batch records in October 2024. Sapio's installed base is in biotech and pharma R&D, and Sapio says 8 of the top 10 pharma companies use its software; GMP manufacturing QC is the market its investor named as an expansion target in 2022, and no named GMP plant deployment is public yet.
Sapio announced GMP LIMS as available on 25 June 2024. It runs on the Sapio lab informatics platform and includes a QC LIMS module, environmental monitoring, and stability management, which Sapio describes as 21 CFR Part 11 and EU Annex 11 compliant. EBR followed on 24 October 2024. (GMP LIMS page; 25 Jun 2024 release; 24 Oct 2024 release.) Target labs: pharmaceutical, biotech, clinical research and diagnostics, food and beverage, chemical, environmental, petrochemical, and cosmetics. A 2026 QC page addresses QC leadership, QA, lab operations, and CDMOs and multi-site organizations, with a scripted Metformin HCl demo. (QC LIMS page.)
The GMP LIMS handles batch and sample management, sampling plans, pass/fail assays, CoA and certificates of release, environmental measurements, stability time points, audit trails, and electronic signatures, plus EBR.
Around it, as separate products:
- The Sapio platform spans ELN, LIMS, sample management, and the ELaiN AI assistant. Platform, discovery, NGS, and chemistry features are not GMP LIMS features. (Platform page.)
- Sapio ELN is separate, though the GMP flyer says the GMP solution "integrates" LIMS and ELN and the stability page is written as "LIMS & ELN." (Flyer HTML; stability page.)
- Sapio Scientific Data Cloud (SDMS), called Jarvis in January 2024. (GxP release, 11 Jan 2024.)
- ELaiN (also Elain), the platform's AI co-scientist.
- MES, QMS, ERP, and serialization are outside scope. EBR covers batch records, materials, equipment status, in-process checks, and QC handoff inside the LIMS, not shop-floor control or warehousing.
- Exemplar LIMS and Exemplar ELN are the product names on U.S. awards from 2007 to 2021.
2. Company and product identity
| Point | Fact | Source |
|---|---|---|
| Product | "Sapio GMP LIMS": "unmatched flexibility for GMP processes." No version number. | GMP page |
| Launch | Baltimore, 25 June 2024: "Sapio GMP (Good Manufacturing Practice) LIMS" is "available now," with QC LIMS, environmental monitoring programs, and stability management. | 25 Jun 2024 release |
| EBR | Baltimore, 24 October 2024: EBR added to Sapio GMP LIMS. | 24 Oct 2024 release |
| Founding | 2004, by Kevin Cramer, still Founder and CEO. | GlobeNewswire / GHO, 1 Dec 2022; leadership |
| Ownership | GHO Capital Partners (LLP per GlobeNewswire; Advisory Ltd. per GHO) announced its investment on 1 December 2022, 7:00 a.m. ET (5:00 a.m. MT). Advisors: Ropes & Gray, AGC, Alvarez & Marsal, Day Pitney, EC Mergers and Acquisitions. Price and stake undisclosed. GHO called Sapio a "scalable SaaS business model" "expanding into the GMP market." | GlobeNewswire; GHO site |
| Locations | Headquarters Baltimore (the same GHO release also says "Based in Pennsylvania"); satellite offices in San Diego, Fort Lauderdale, London, and York, PA in 2022. The current footer lists Baltimore, London, and York. | GlobeNewswire; GMP page footer |
| Contracting | SAPIO SCIENCES, LLC, UEI Z5DXSDZGWK88. Older awards use York, PA; the 2013 FDA award uses 400 E Pratt St, Ste 800, Baltimore. | 2010 LIMS award; 2013 GIMS award |
| Earlier names | "EXEMPLAR ELN," "SAPIO EXEMPLAR LIMS&DATA DESIGNER," "EXEMPLAR ANALYSIS." | Award payloads |
3. Pharma and biotech relevance
- Drug-product QC. The QC LIMS module covers drug product registration, batch creation, sampling plans, analytical tests, automatic pass/fail, trending, and a CoA or Certificate of Release with electronic signatures. (GMP page.)
- Part 11 and Annex 11. The GMP page, the environmental-monitoring page, and both 2024 releases call the solution 21 CFR Part 11 and EU Annex 11 compliant.
- Stability and environmental monitoring. Stability covers storage conditions, time points, and shelf life. Environmental monitoring covers sites, equipment, and sampling plans, including "AI-powered" plan generation from site images. (GMP page; EM page.)
- EBR. Templates, role-based steps, barcode and weight tracking, equipment calibration status, in-process control, deviation records, and an immutable audit log. (EBR page.)
- GAMP 5. On 11 January 2024 Sapio said its unified LIMS, ELN, and scientific data cloud, including the cloud-hosted environment, had been validated to ISPE GAMP 5, 21 CFR Part 11, and Annex 11 for GMP, GLP, and GCP use. That announcement predates the June 2024 GMP modules and the October 2024 EBR. (GxP release; Contract Pharma, 11 Jan 2024.)
Customer claims: "8 out of the top 10 pharmaceutical companies use Sapio," without naming the product; Sapio calls itself "#1" and the "clear leader in biotech lab information systems." (Customers.) GHO's 2022 release names Bristol Myers Squibb, GSK, J&J, Charles River, and LabCorp as customers, before GMP LIMS existed.
4. Capabilities
| Capability | Type | What Sapio documents | Source |
|---|---|---|---|
| Drug product and batch registration | QC module | Configurable dashboards, unique drug product registration, batch creation with metadata. | GMP page; June 2024 release |
| Sampling | QC module | Automatic sampling plans, sample request and rejection, storage. | GMP page |
| Assays and pass/fail | QC module | Manual and automated result entry, pre-configured assays and acceptance criteria, automatic pass/fail, multiple parameters per sample, trending within and across batches. | GMP page |
| CoA and Certificate of Release | QC module | Automatic CoA and Certificate of Release with electronic signatures; CoA embedded in the release certificate. | GMP page; June 2024 release |
| Assay configuration | QC page (2026) | Published templates dragged into unit operations; warning ranges separate from acceptance limits; dual e-signature by two different people; published versions locked, changes create a new version; "18+ reusable assay templates." | QC page |
| Environmental monitoring | Module | Routine and non-routine plans, scheduling, result entry, automatic evaluation and alerts, trend charts and heat maps, equipment and hierarchical storage, AI plan generation from site images. | GMP page; EM page |
| Stability | Module | Study types, storage conditions, durations, time points, automatic test requests, evaluation against criteria, summary reports, degradation and shelf life. | GMP page |
| EBR | Module (October 2024) | No-code templates; executor and inspector roles; step signatures; raw-material lots; barcodes; weights; equipment calibration status; in-process and final QC; deviations; immutable audit log; batch report. | October 2024 release; EBR page |
| Audit trail and access | Native | Audit trails, electronic signatures, permission-based access; "immutable audit log" in EBR. | GMP page; EBR page |
| Deviations | Native | Workflow steps or deviations flagged for review; deviation records in EBR. No CAPA module. | GMP page; EBR page |
| ELaiN reports | Platform | "ELaiN, the AI co-scientist built into the platform": prompts, scheduled email, "works with Claude, Copilot, ChatGPT, Gemini," access-controlled and logged. | QC page |
The general Sapio LIMS adds chain of custody, plate setup, robotics instructions, and reagent lots (LIMS page); the platform adds CRISPR, plasmid design, flow cytometry, NGS, and histopathology tools. Neither set is listed for GMP LIMS.
5. Architecture and deployment
The general Sapio LIMS runs in the cloud or on-premises. (LIMS page.) The January 2024 validation covered "Sapio's cloud-hosted environment," and the 2024 GMP releases describe "Our cloud-based solutions — LIMS, ELN, and Scientific Data Management." Sapio publishes no version, reference architecture, data-residency region, RPO/RTO, or GMP-specific security white paper. Sapio sells rollout in "six stages, one afternoon" (QC page) and "weeks, not years" (consulting page).
6. Integrations
| Interface | What Sapio documents |
|---|---|
| GMP equipment | Environmental monitoring: "equipment integration for automated result capture." EBR: final QC "capturing results from integrated instruments." |
| Platform instruments | Predefined configurations "from ABI Bioanalyzers to LCMS" (Bio-Rad qPCR, SpectraMax), otherwise custom. Rules Engine (no-code triggers), File Bridge (directories), RESTful API (query and create records), and HL7 "for sensitive data exchanges." Java and Python specialists available. |
| Instrument library | "A library of 200+ instruments supported via file sweet, and a flexible API" (consulting FAQ). |
| ELN | Stability uses "Integration with the ELN" for protocols and reports. |
| Waters | Article "Streamlining Lab Workflows with Sapio LIMS and waters_connect for Quantitation"; Waters logo on the partner page. |
| Partners | AWS, NVIDIA BioNeMo, ChemAxon, CCDC, Elsevier, OpenEye, Optibrium, Schrödinger, Simulations Plus, mostly tied to ELaiN and discovery. Cognizant "transform[s] manufacturing QC and R&D labs through cloud-enabled lab solutions." IQVIA and LabCorp appear for clinical and diagnostics. |
| Webhooks | "Sapio Webhooks" add-on. |
Sapio lists no SAP, Oracle, Veeva, or MasterControl connector for GMP LIMS. Its April 2025 summary of Gartner's LIMS Market Guide says LIMS is converging with MES, QMS, and PLM.
7. Pricing and commercial model
Pricing is quote-only. Sapio publishes no price for GMP LIMS. The pricing page offers "a pricing proposal tailored to your needs." (Pricing.) It lists, without prices:
- Sapio LIMS add-ons: ad-hoc charting, group management, data field designer, data type designer, remote workers, webhooks, instrument management and maintenance tracking, "Sapio LIMS Add-On," Sapio Analytics, and "many optional add-ons."
- A combined "Sapio ELN + LIMS" column.
- Bundles: Clinical and Diagnostics, Laboratory Platform, Scientific Data Cloud, Biotech Research and Discovery, NGS, Chemistry, Sample Management, Bioanalytical, Multimodal Discovery, and Patient Portal. GMP LIMS is not a bundle; "LIMS GMP" appears only in the footer, beside a "Sapio Seamless ELN Bronze" sign-up.
Validation is sold separately: a "premium validation package" by subscription and a purchasable "validation starter pack." (GxP release.) The QC page shows illustrative "Annual Value" ranges for a representative lab with about 10 method changes and 2–4 false OOS events a year: $50,000–$200,000, $30,000–$150,000, $20,000–$100,000, and $50,000–$250,000. These are benefit estimates, not fees.
Public contract records
USAspending lists 8 awards to SAPIO SCIENCES, LLC; none mentions GMP. All predate the GMP product.
| PIID | Signed | Obligated (USD) | Description | Buyer | Terms |
|---|---|---|---|---|---|
| HHSN263200800033P | 2007-10-18 | 12,950 | EXEMPLAR ANALYSIS (ALL MODULES) and support | HHS | PSC J066; pricing code 3 |
| HHSN263200900075P | 2008-10-29 | 8,675 | MAINT-REP OF ADP EQ & SUPPLIES | HHS | PSC J070 |
| W81XWH10P0520 | 2010-09-16 | 65,000 | LABORATORY INFORMATION MANAGEMENT SYSTEM | Army medical research contracting | PSC 7030; NAICS 511210; pricing code J; competed under SAP, 3 offers; 16–24 Sep 2010, York, PA |
| W81XWH11P0362 | 2011-06-10 | 24,000 | SAPIO EXEMPLAR LIMS&DATA DESIGNER | Same | PSC D313; pricing code J; one offer |
| W81XWH12P0157 | 2012-02-13 | 25,516.67 (with options 96,716.67) | BASE YEAR - LIMS | Same | PSC 7030; pricing code J |
| HHSF223201300409A | 2013-09-13 | 0 | GENOMIC INFORMATION MANAGEMENT SYSTEM | FDA | Baltimore; SAM.gov award notice FDA-SOL-13-1119904 |
| 75N93019P01194 | 2019-09-13 | 24,360 | ELN PROFESSIONAL CONCURRENT USERS | NIH NIAID | PSC 7030 |
| 75N93021P00039 | 2020-10-30 | 24,847 | EXEMPLAR ELN PROFESSIONAL CONCURRENT USER | NIH NIAID | PSC J066; not competed under SAP, one offer |
An EU TED search on 3 Oct 2026 found no notice naming Sapio Sciences.
Questions a buyer should ask
- Is GMP LIMS a separate license or a configuration of Sapio LIMS? Which of QC, environmental monitoring, stability, and EBR are included?
- Named user, concurrent user, site, module, or batch volume? Past federal buys were concurrent ELN users.
- Cloud or on-prem for GMP, who hosts, and where does GxP data reside?
- Is the ELN required for the stability and GMP workflows, and priced separately?
- Are instrument parsers, File Bridge, webhooks, and the REST API in the software price?
- Do the validation package and starter pack cover the June 2024 modules and October 2024 EBR, and what does the buyer still validate?
- What does "immutable" mean: who can archive, migrate, or correct a signed record?
- Is the dual-approval publish flow on the QC page the shipping configuration?
- Does "weeks, not years" include data migration and Part 11 testing?
- How are existing Exemplar-era systems treated in the quote?
8. Implementation and validation support
Sapio's consulting team covers business analysis, LIMS workflow design and implementation, data assessment, migration and standardization, dashboards, ELN templates, system and instrument integration, training, and reports, promising rollout in "weeks, not years" with "little to no custom code." It cites a "46% rise in System Usability Score," "78% rise in user adoption," and "10x improvement in productivity," and quotes an unnamed "Scientific Leader, Large Pharma." (Consulting.)
Partners carry Sapio Certified Platform Engineer, Sapio Verified Deployment, and Sapio Certified Partner marks. Named services partners include Cognizant, Zifo, Astrix, CSols, Kalleid, Leap Consulting Group, EPAM, Excelra, and ZS. (Partner program.)
Validation: the January 2024 GAMP 5, Part 11, and Annex 11 platform validation (section 3), with "GxP foundation documentation" by subscription and a starter pack; the partner page shows a "gxp ispe gamp 5 validated" badge. No IQ/OQ/PQ set or GAMP software category is published.
Security credentials (company level): SOC 2 Type II (auditor Schellman & Company, LLC), ISO 27001, HIPAA, GDPR, the EU-U.S. Data Privacy Framework with UK and Swiss extensions, French HDS, a DPA, and standard contractual clauses. The January 2024 release dates ISO/IEC 27001:2013 accreditation to 23 August 2023, the SOC 2 Type II period to 1 November 2022 through 30 June 2023, and a HIPAA Type 1 report to 30 June 2023. (Credentials.)
9. Customer evidence
No named GMP manufacturing site runs Sapio GMP LIMS on the public record.
| Account | Evidence | Limit |
|---|---|---|
| Zifo | Case study "Zifo and Sapio Improving QC Lab Efficiency" (gated). | Partner-authored. |
| Oxford Biomedica | Implemented Sapio ELN (18 July 2023; CIO Matthew Treagus quoted); later case study on "Enterprise-Wide Lab Informatics Standardization" (gated). | ELN. |
| Bristol Myers Squibb, GSK, J&J, Charles River, LabCorp | Named in the 2022 GHO release. | Pre-GMP LIMS. |
| Baylor College of Medicine, Human Genome Sequencing Center | Jianhong Hu, Director of Clinical Laboratory, on Sapio LIMS process tracking. | Genomics clinical lab. |
| Janssen | "Enabling Janssen's Next Leap in Drug Discovery With Sapio LIMS." | Discovery. |
| LabConnect, NatureMetrics, PTC Therapeutics, Schrödinger, ImmuneBridge, Ellison Institute, Wellcome Sanger, Genseq, UCSF, evitria, Navignostics | Case-study titles: clinical trials, NGS, discovery, ELN, cancer diagnostics, antibody workflows. | Other Sapio uses. |
| Unnamed "Scientific Leader, Large Pharma," "Director, Small Biotech," "Senior Director, Clinical Research Organizations" | Short quotes. | No employer. |
| U.S. Army, NIH NIAID, FDA | Purchases of earlier Sapio software (section 7). | Pre-GMP LIMS. |
10. Competitive and third-party context
Sapio reports two Gartner mentions:
- Gartner's 2024 Hype Cycle for Life Science Manufacturing, Quality and Supply Chain lists Sapio under SaaS LIMS, "moderate benefit," with adoption rising over two to five years. (Vendor post.)
- Gartner's 2025 Market Guide for LIMS (Baltimore, 16 April 2025) names Sapio a representative vendor for R&D-centric biotechnology companies and calls out ELaiN. (Vendor post.)
Contract Pharma (Anthony Vecchione, 11 January 2024) reported the platform GxP validation. (Contract Pharma.) No Forrester or IDC evaluation is cited, and no ISPE paper certifies the product.
On 3 Oct 2026, openFDA 510(k), registration listing, device event, drugsfda, and drug enforcement data returned no Sapio match. FDA's and EMA's site searches could not be queried, so no inspection record is cited. FDA's 2013 contract with Sapio was a genomic-system purchase, not a clearance.
11. Changes and renames
- 2004: Sapio Sciences founded by Kevin Cramer.
- 2007–2021: federal buyers purchase Exemplar Analysis, Exemplar LIMS, a LIMS base year, and Exemplar ELN users.
- 2013-09-13: FDA genomic information management system award.
- 2022-12-01: GHO Capital invests; GMP named as an expansion market.
- 2024-01-11: platform GxP validation (GAMP 5, Part 11, Annex 11), cloud hosting included; validation packages offered.
- 2024-06-25: Sapio GMP LIMS launched with QC, environmental monitoring, and stability.
- 2024-10-24: EBR added.
- 2025-04-16: Gartner 2025 LIMS Market Guide mention.
- 2026: QC page adds self-service assay publishing and illustrative annual value. Jarvis is now Sapio Scientific Data Cloud.
12. Source library
Pages retrieved 2026-10-03. Full URL list: sources note. Every claim above is in the product's evidence set with its source, type, and confidence.
Primary pages:
- https://www.sapiosciences.com/solutions/gmp-lims/
- https://www.sapiosciences.com/solutions/qc-lims/
- https://www.sapiosciences.com/news/sapio-gmp-lims-unmatched-flexibility-sapio-sciences/
- https://www.sapiosciences.com/news/sapio-adds-electronic-batch-record-functionality-to-unified-gmp-lims-solution/
- https://www.sapiosciences.com/solutions/sapio-ebr/
- https://www.sapiosciences.com/products/lims/
- https://www.sapiosciences.com/sapio-pricing/
- https://www.sapiosciences.com/news/sapio-sciences-announces-full-gxp-validation-of-its-unified-lab-informatics-platform-and-suite-of-solutions/
- https://www.globenewswire.com/news-release/2022/12/01/2565750/0/en/GHO-Capital-invests-in-Sapio-Sciences-a-leading-high-growth-lab-informatics-platform-company.html
Sources note
Sources: Sapio GMP LIMS
Sources as of 3 Oct 2026. Each entry gives the source and what it supports in the profile.
Vendor and company
- GMP-Compliant Lab Informatics / Sapio GMP LIMS: Current name, QC/EM/stability feature lists, Part 11 and Annex 11 claim, ELN mention on stability
- GMP QC LIMS with Self-Service Process Configuration: Dual e-sign, version freeze, scripted Metformin demo, annual-value dollars, ELaiN
- Laboratory Information Management System (LIMS): General LIMS, cloud or on-premise bullet, not a GMP spec
- Introduces Sapio GMP LIMS, 25 Jun 2024: Announcement and “available now”
- EBR added, 24 Oct 2024: EBR inside GMP LIMS
- Sapio Electronic Batch Records: EBR feature list
- Sapio Environmental Monitoring Software: EM module and Part 11 / Annex 11 claim
- Stability Monitoring with Stability LIMS: Written as LIMS and ELN.
- Sapio Pricing: Proposal only. Add-on names. No currency amount
- GMP LIMS Product Flyer: HTML abstract. Says the solution integrates LIMS and ELN.
- Lab informatics platform: Adjacent platform, ELN, Elain
- Lab Instrument Integration: Rules Engine, File Bridge, REST, HL7, example instruments
- Sapio Laboratory Consulting: Services list, “file sweet,” 200+ claim, unnamed pharma quote
- Partner program: Ecosystems, certification names, Cognizant sentence, logo alts, GAMP badge alt
- Security and privacy credentials: SOC 2, ISO 27001, HIPAA, DPF, HDS, GDPR.
- Full GxP validation, 11 Jan 2024: Platform claim, GAMP 5, cloud-hosted environment, validation pack
- Customer community: Titles and the “8 out of the top 10” line.
- Pharmaceutical organizations: GMP card reuses a chemistry sentence.
- About: Values page. Does not state founding year
- Leadership: Kevin Cramer, Founder and CEO
- Oxford Biomedica implements Sapio ELN, 18 Jul 2023: ELN selection. Not GMP LIMS. Matthew Treagus quoted
- Vendor account of a 2024 Gartner Hype Cycle: SaaS LIMS mention, as told by Sapio.
- Vendor account of the 2025 LIMS Market Guide, 16 Apr 2025: Representative-vendor wording and ELaiN.
Press and third parties
- globenewswire.com/news-release/2022/12/01/2565750/0/en/GHO-Capital-invests-in-Sapio-Sciences-a-leading-high-growth-lab-informatics-platform-company.html: 1 Dec 2022, 7:00 a.m. ET (5:00 a.m. MT). Founded 2004. Investment, no price. SaaS wording. Named customers. “Expanding into the GMP market.”
- ghocapital.com/updates/gho-capital-invests-in-sapio-sciences/: Same announcement on the investor site. Entity styled GHO Capital Partners Advisory Ltd. on that page.
- contractpharma.com/breaking-news/sapio-granted-full-gxp-validation-of-lab-informatics-platform/: 11 Jan 2024 trade-press restatement of the platform GxP claim